Based on the negative association between CSF-1 and infiltration of CD8+ T cells, we assumed that CSF-1 is a critical factor in regulating the CSF-1R+CD11c+ MDSC cells in the TME and can thus prevent tumor elimination mediated by the trametinib/αPD-1 combination. The gene discussed is CD8A; the disease is neoplasm.